Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001304280 | SCV001493553 | uncertain significance | Nephronophthisis | 2023-07-21 | criteria provided, single submitter | clinical testing | Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPHP4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 1007139). This variant has not been reported in the literature in individuals affected with NPHP4-related conditions. This variant is present in population databases (rs201680615, gnomAD 0.007%). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 285 of the NPHP4 protein (p.Arg285Trp). |
Ambry Genetics | RCV004960720 | SCV005464533 | uncertain significance | Inborn genetic diseases | 2024-10-09 | criteria provided, single submitter | clinical testing | The c.853C>T (p.R285W) alteration is located in exon 8 (coding exon 7) of the NPHP4 gene. This alteration results from a C to T substitution at nucleotide position 853, causing the arginine (R) at amino acid position 285 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005029888 | SCV005656294 | uncertain significance | Nephronophthisis 4; Senior-Loken syndrome 4 | 2024-03-22 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV004815308 | SCV005068992 | uncertain significance | Retinal dystrophy | 2023-01-01 | no assertion criteria provided | clinical testing |